Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Comorbidities and race/ethnicity among adults with stimulant use disorders in residential treatment.

Sanchez K, Chartier KG, Greer TL, Walker R, Carmody T, Rethorst CD, Ring KM, Dela Cruz AM, Trivedi MH.

J Ethn Subst Abuse. 2015;14(1):79-95. doi: 10.1080/15332640.2014.961109. Epub 2015 Jan 12.

2.

A Health Education Intervention as the Control Condition in the CTN-0037 STRIDE multi-site exercise trial: Rationale and Description.

Rethorst CD, Greer TL, Grannemann B, Ring KM, Marcus BH, Trivedi MH.

Ment Health Phys Act. 2014 Mar 1;7(1):37-41.

3.

Rationale for Using Exercise in the Treatment of Stimulant Use Disorders.

Greer TL, Ring KM, Warden D, Grannemann BD, Church TS, Somoza E, Blair SN, Szapocznik J, Stoutenberg M, Rethorst C, Walker R, Morris DW, Kosinski AS, Kyle T, Marcus B, Crowell B, Oden N, Nunes E, Trivedi MH.

J Glob Drug Policy Pract. 2012 Spring;6(1). pii: http://ctndisseminationlibrary.org/display/825.htm.

4.

Stimulant reduction intervention using dosed exercise (STRIDE) - CTN 0037: study protocol for a randomized controlled trial.

Trivedi MH, Greer TL, Grannemann BD, Church TS, Somoza E, Blair SN, Szapocznik J, Stoutenberg M, Rethorst C, Warden D, Ring KM, Walker R, Morris DW, Kosinski AS, Kyle T, Marcus B, Crowell B, Oden N, Nunes E.

Trials. 2011 Sep 19;12:206. doi: 10.1186/1745-6215-12-206.

5.

Determining the primary endpoint for a stimulant abuse trial: lessons learned from STRIDE (CTN 0037).

Trivedi MH, Greer TL, Potter JS, Grannemann BD, Nunes EV, Rethorst C, Warden D, Ring KM, Somoza E.

Am J Drug Alcohol Abuse. 2011 Sep;37(5):339-49. doi: 10.3109/00952990.2011.598589.

6.

Beta2-adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans.

Herrmann V, Büscher R, Go MM, Ring KM, Hofer JK, Kailasam MT, O'Connor DT, Parmer RJ, Insel PA.

Am J Hypertens. 2000 Sep;13(9):1021-6.

PMID:
10981553
7.

Variability in phenylephrine response and essential hypertension: a search for human alpha(1B)-adrenergic receptor polymorphisms.

Büscher R, Herrmann V, Ring KM, Kailasam MT, O'Connor DT, Parmer RJ, Insel PA.

J Pharmacol Exp Ther. 1999 Nov;291(2):793-8.

PMID:
10525102
8.

Avoiding the legal pitfalls of unlimited agency provisions in health care network provider contracts.

Ring KM.

Med Interface. 1996 Feb;9(2):68-70, 72. No abstract available.

PMID:
10154841
9.

Nanometer-resolved spatial variations in the Schottky barrier height of a Au/n-type GaAs diode.

Talin AA, Williams RS, Morgan BA, Ring KM, Kavanagh KL.

Phys Rev B Condens Matter. 1994 Jun 15;49(23):16474-16479. No abstract available.

PMID:
10010799
10.

Selective macropinocytosis of thyroglobulin in rat thyroid follicles.

Ericson LE, Ring KM, Ofverholm T.

Endocrinology. 1983 Nov;113(5):1746-53.

PMID:
6628324

Supplemental Content

Support Center